Treatment Action Group is an independent AIDS research and policy think tank fighting for better treatment, a vaccine, and a cure for AIDS. TAG’s TB/HIV Project works to strengthen global and U.S.-focused advocacy to increase funding and ensure ambitious and improved research, programs, and policy to ensure universal access to quality services for people with TB and HIV. The project works: to catalyze global leadership to accelerate momentum toward universal access for high-quality TB and TB/HIV services including implementation of the revised WHO policy on collaborative TB/HIV activities; and to accelerate funding and progress in R&D for better tools to prevent, diagnose, and treat TB. TAG advocates for investment in and development of: rapid drug susceptibility test (DST) assays that enable more people, especially children and people living with HIV to receive accurate diagnosis for drug-resistant TB; and novel drugs and regimens that are less toxic, more efficacious, and can achieve cure in less time than existing treatments.
For more information and resources from Treatment Action Group (TAG), please visit: http://www.treatmentactiongroup.org